PCI The Journeys Within
Media Pack
News

Current Edition

JCS - Volume 18 Issue 3 - Autumn 2026
Frankfurt 2027 – 12/10/26
ramusmedical
Regional News

Former Mylan executive pleads guilty to insider trading that netted him $4.27M

A former Mylan executive has pleaded guilty to an insider trading scheme that netted him $4.27 million. After leaving the company in 2017, Dayakar Mallu received info...
22 September 2021 Regional News FDA | insider trading
Continue Reading →
Regional News

Biogen beefs up in biosimilars—again—with FDA nod for Samsung-partnered Lucentis copycat

Even as Biogen dominates biopharma headlines with its high-profile Aduhelm launch, the company's budding biosimilar business has been quietly building up—and now, it ...
22 September 2021 Regional News Biogen | biosimilars
Continue Reading →
Regional News

Pfizer plans to seek FDA nod for COVID-19 shot in kids 5 to 11 after positive data

With coronavirus cases on the rise among children, Pfizer and BioNTech brought welcome news on Monday, reporting their COVID-19 vaccine is safe and generated a strong...
22 September 2021 Regional News COVID-19 | FDA
Continue Reading →
Regional News

Merck women’s health spinoff Organon debuts first awareness campaign, taking on unplanned pregnancy

When Merck's women’s health spinoff Organon launched in June, it promised to listen to—and amplify—women’s voices on overlooked health concerns. Now, the company is ...
22 September 2021 Regional News Merck | Organon
Continue Reading →
Regional News

Amgen scores Otezla patent win, protecting its blockbuster from Sandoz and Zydus generics until 2028

When Amgen bought marketing rights to psoriasis pill Otezla for $13.4 billion two years ago, the company was likely counting on not having to compete against early ge...
22 September 2021 Regional News Amgen | Otezla
Continue Reading →
Regional News

Fred Hutch researchers tout Iclusig’s potential to tame cytokine storm in COVID but can’t get Takeda on board

Researchers at the Fred Hutchinson Cancer Research Center in Seattle say they have uncovered an FDA-approved drug that may be effective in combating the often-lethal ...
16 September 2021 Regional News Cancer Research Center | cytokine
Continue Reading →
Regional News

Amid COVID’s latest surge, Regeneron and Eli Lilly score new antibody supply deals with the U.S.

During a call with analysts last month, Regeneron said it didn’t expect to record additional sales of its COVID-19 antibodies to the United States this year. But les...
16 September 2021 Regional News antibody | COVID
Continue Reading →
Regional News

Citing ‘less-than-optimal’ outcomes for Roche’s Evrysdi, Biogen launches high-dose Spinraza trial

While much of the attention on Biogen lately has centred on its launch of controversial Alzheimer's disease drug Aduhelm, the company is also feeling the heat from a ...
16 September 2021 Regional News Aduhelm | Alzheimer's
Continue Reading →
Regional News

ALS Ice Bucket Challenge advocacy group calls for speedy FDA approval of Amylyx now-pending drug

The ALS Association, known for its Ice Bucket Challenge fundraising, is pushing for a speedy FDA approval of Amylyx's now-pending ALS candidate submission—but is hist...
16 September 2021 Regional News ALS Ice Bucket Challenge | Amylyx
Continue Reading →
Regional News

Floating material found in Pfizer COVID-19 vaccine vials in Japan, but company says it’s not contamination

In recent weeks, Moderna has had to deal with reports of contaminants discovered in vials of its COVID-19 vaccine in Japan. Now it’s Pfizer doing the same after whit...
16 September 2021 Regional News COVID-19 | Japan
Continue Reading →
Quotient
jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte